IN8BIO, Inc.
INAB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001740279
No open-market purchases or sales by IN8BIO, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $5.35M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding IN8BIO, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 32 | 26 | −6 |
| Shares | 8.64M | 7.74M | −898.1K (−10.4%) |
| Value | $10.2M | $6.77M | −$3.45M (−33.8%) |
New holders (3)
Institutions that held IN8BIO, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 10,813 | $9.00K | 0.00% |
| HighTower Advisors, LLC | 10,000 | $8.00K | 0.00% |
| Bank of America Corp | 266 | $225 | 0.00% |
Sold out (9)
Institutions that held IN8BIO, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Renaissance Technologies LLC | 119,155 | $141.0K |
| Two Sigma Investments, LP | 41,528 | $49.0K |
| Millennium Management LLC | 32,557 | $38.4K |
| Wela Strategies, Inc. | 18,548 | $21.9K |
| Ground Swell Capital, LLC | 16,356 | $19.3K |
| Virtu Financial LLC | 14,044 | $17.0K |
| Goldman Sachs Group Inc | 11,612 | $13.7K |
| Vontobel Holding Ltd. | 10,000 | $11.8K |
| Wells Fargo & Company | 247 | $291 |